About J-ARM
J-ARM is a Healthcare company based in Osaka (Japan) founded in 2006. It operates as a developer of lymphocyte therapy and stem cell therapy for dogs and cats. Its focus areas include HealthTech, Veterinary HealthTech, Biopharmaceuticals and Companion Animals. Its competitors include Gallant, eQcell, Bioceltix, Nupsala and Vetherapy and 4 more; 7 of its 9 listed competitors have raised funding.
Company details
J-ARM was founded in 2006 in Osaka, Japan, within the veterinary biotechnology sector. Lymphocyte therapy and stem cell therapy are developed by the company for application in animal hospitals, cosmetic surgery procedures, and immunoclinics targeting cancer in dogs and cats. Operations focus on these regenerative treatments to support pet health care.
- Headquarters Osaka, Japan
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website j-arm.biz
- Investors
Funding Insights of J-ARM
- Total Rounds 2
- Investors Count 1
1 investors in total: 1 institutional.
Investors in J-ARM
J-ARM has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Japan Asia Investment.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity platform is operated for investing in growth-oriented companies. | 1981 | jaic-vc.co.jp | Tokyo, Japan |
Investor details for J-ARM
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of J-ARM
3 dated milestones of J-ARM across 17 years, from founding to its latest funding, stage changes and deals.
- Founded J-ARM is founded.
- Funding First funding round.
- Funding Latest funding round, Seed,.
Competitors of J-ARM
J-ARM has 9 listed competitors in our database, 7 of them funded. They include Gallant, eQcell, Bioceltix, Nupsala and Vetherapy, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| gallant.com | 2018 | Los Angeles, United States | $61.46M | – | Stem cell storage for canine regenerative therapy is offered. | |
| eqcell.com | 2010 | Guelph, Canada | $4.6M | 8 | Stem cell therapies for animal health are developed. | |
| bioceltix.com | 2017 | Wroclaw, Poland | – | – | Developer of drugs for veterinary therapy | |
| nupsala.com | 2012 | Melton Mowbray, United Kingdom | $192,595 | 16 | Veterinary pharmaceuticals and products are supplied alongside educational resources. | |
| vetherapy.co | 2015 | San Francisco, United States | $250,000 | – | Provider of stem cell therapies for pets | |
| vetbiobank.com | 2011 | – | $450,237 | – | Veterinary regenerative medicine | |
| revatis.com | 2013 | Luxemburg, United States | – | – | Undifferentiated muscle-derived stem cells are obtained via patented micro-biopsy technology. | |
| actcells.com | 2008 | San Diego, United States | $10.11M | – | Research and development of veterinary stem cell | |
| theracellinc.com | 2008 | Northridge, United States | $1.42M | – | Allograft solutions for spinal surgery are provided by TheraCell. |
Detailed competitors of J-ARM
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of J-ARM
The website of J-ARM (j-arm.biz) receives about 2.4K visits a month.
- Monthly visits2.4K
▲ 20.5% vs previous month
Top companies in Veterinary Digital Health
10 companies that operate in the same segment as J-ARM (Veterinary Digital Health), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Practice and prescription management software is provided for veterinary professionals. | 2010 | Portland, Oregon, United States | USD 291.64 M | – | – | |
Animal medicines, vaccines, and diagnostics are manufactured and supplied. | 2012 | Brussels, Brussels-capital Region, Belgium | – | – | – | |
Veterinary pharmacy services are delivered by VetSource to practices. | 2005 | Portland, Oregon, United States | USD 81.25 M | – | – | |
Animal health therapeutics are developed and supplied globally by Ceva. | 1999 | Libourne, Nouvelle-aquitaine, France | USD 214.35 M | – | – | |
Digital platform for pet insurance | 2020 | Stockholm, Sweden | USD 114.08 M | – | – | |
App based platform providing veterinary services and clinical management solutions for veterinarians | 2018 | Beverly Hills, California, United States | USD 58.81 M | – | – | |
Online client communication platform for veterinary doctors | 2013 | San Diego, California, United States | USD 14.11 M | USD 14.38 M | 1 | |
Virtual veterinary care is provided via an app platform. | 2018 | Los Angeles, California, United States | USD 210 M | – | 163 | |
Comprehensive customer engagement platform for veterinary clinics is provided. | 2015 | Austin, Texas, United States | USD 50.3 M | – | – | |
Veterinary appointments are booked via an online platform. | 2017 | Brooklyn, New York, United States | USD 243 M | – | 64 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about J-ARM
J-ARM was founded in 2006 and raised its 1st funding round 10 years after it was founded.
J-ARM is headquartered in Osaka, Japan. It is registered at Osaka, Osaka Prefecture, Japan.
J-ARM was founded in 2006 in Osaka, Japan, within the veterinary biotechnology sector. Lymphocyte therapy and stem cell therapy are developed by the company for application in animal hospitals, cosmetic surgery procedures, and immunoclinics targeting cancer in dogs and cats. Operations focus on these regenerative treatments to support pet health care.
J-ARM has 1 investor. Key investors include Japan Asia Investment.